SuT-S, LuH-Z, Cheng. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm. BMC Cancer, 2016; 16:834.
2.
KennedyAS. Radiation oncology approaches in liver malignancies. Am Soc Clin Oncol Educ Book, 2014; 34:e150.
3.
HuoYR, EslickGD. Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: A systematic review and meta-analysis. JAMA Oncol, 2015; 1:756.
4.
JansenMC, van HillegersbergR, ChamuleauRA, et al.Outcome of regional and local ablative therapies for hepatocellular carcinoma: A collective review. Eur J Surg Oncol, 2005; 31:331.
5.
EggertT, GretenTF. Current standard and future perspectives in non-surgical therapy for hepatocellular carcinoma. Digestion, 2017; 96:1.
6.
SalemR, GordonAC, MouliS, et al.Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology, 2016; 151:1155.
7.
Hardy-AbeloosC, LazarevS, RuM, et al.Safety and efficacy of liver stereotactic body radiation therapy for hepatocellular carcinoma after segmental transarterial radioembolization. Int J Radiat Oncol Biol Phys, 2019; 105:968.
8.
HondaY, KimuraT, AikataH, et al.Pilot study of stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma. Hepatogastroenterology, 2014; 61:31.
9.
OladeruOT, MiccioJA, YangJ, et al.Conformal external beam radiation or selective internal radiation therapy—A comparison of treatment outcomes for hepatocellular carcinoma. J Gastrointest Oncol, 2016; 7:433.
10.
MohamedM, KatzAW, TejaniMA, et al.Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma. Adv Radiat Oncol, 2015; 1:35.
